COVID-19 Records

Transcript segment

Baric Transcribed Interview (Redacted), p.130 · baric_ti:utt:01114

Page text: p.130 · original PDF

Date
2026-04-10 09:00 (day precision)
Type
transcript segment · interview
recipient
Ralph S. Baric, Christina Salazar, Harry Kazenoff, David T. Lambeth III, Clark Ervin, Jake Greenberg
speaker
William Henderson
Back to the February 1st call, you said that you did not recall and could not figure out how you got added to that call. Was there any suggestion or implication or direction to you not to speak up on that call?

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

  1. 2026-04-10 09:00 Ralph S. Baric open
    Okay. So basically there's a massive inflammatory response that has the potential to be lifethreatening, and the SARS coronavirus vaccines, from 2003, that the NIH had purchased, were both adjuvanted with alum. And we published papers showing that that drives a strong Th2 immune response. So my concern, and I expressed this to the WHO and to other groups, was that we needed to look carefully for vaccine-induced immune pathology. Ultimately, we published a paper with the VRC. That was one of the experiments we set up to do, where we took mRNA vaccines and we took killed vaccine preparations with alum and compared them head-to-head for the ability to induced Th2 responses. The mRNA vaccines did not cause it. The recombinant protein, or the killed vaccines plus alum caused a big Th2 response. Now, the Chinese vaccines were killed vaccines with alum, which I think was inappropriate. The mRNA vaccines, though, were tested for that using homologous virus challenge. DC.Scheduling@LexitasLegal.com
  2. 2026-04-10 09:00 Christina Salazar open
    Okay. So at this point --
  3. 2026-04-10 09:00 Ralph S. Baric open
    At that point, the downstream question is whether if you have significant amounts of virus variation and you're infecting the original Wuhan mRNA vaccine, will breakthrough infection induce an immune pathology phenotype, and those are the kinds of things we're interested in studying now.
  4. 2026-04-10 09:00 Christina Salazar open
    Okay. Let's see. William had a followup question, so I'll let you do that one.
  5. 2026-04-10 09:00 William Henderson
    Back to the February 1st call, you said that you did not recall and could not figure out how you got added to that call. Was there any suggestion or implication or direction to you not to speak up on that call?
  6. 2026-04-10 09:00 Ralph S. Baric open
    So again, I'm kind of surprised that they didn't know I was there.
  7. 2026-04-10 09:00 Christina Salazar open
    Did you introduce yourself?
  8. 2026-04-10 09:00 Ralph S. Baric open
    I think so, yes. I think so, yeah. I think we went around and introduced everybody in the room. My problem is I couldn't find the link that told me exactly how I got on that call, and I think it may have been a personal, like a phone call, you need to be on this call, here's the link, or something like that. But I can't find a record of it, and I've looked incredibly hard.
  9. 2026-04-10 09:00 Christina Salazar open
    Is there any chance that someone dialed DC.Scheduling@LexitasLegal.com you in, patched you in?

Full conversation →